[go: up one dir, main page]

WO2007114482A1 - Process for production of sugar chain compound - Google Patents

Process for production of sugar chain compound Download PDF

Info

Publication number
WO2007114482A1
WO2007114482A1 PCT/JP2007/057614 JP2007057614W WO2007114482A1 WO 2007114482 A1 WO2007114482 A1 WO 2007114482A1 JP 2007057614 W JP2007057614 W JP 2007057614W WO 2007114482 A1 WO2007114482 A1 WO 2007114482A1
Authority
WO
WIPO (PCT)
Prior art keywords
sugar chain
group
formula
compound represented
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2007/057614
Other languages
French (fr)
Japanese (ja)
Inventor
Yasuhiro Kajihara
Yuri Nambu
Kazuhiro Fukae
Hiroaki Asai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Chemical Co Ltd
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Publication of WO2007114482A1 publication Critical patent/WO2007114482A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • the present invention relates to a method for producing a sugar chain compound having a free hydroxyl group at the reducing end by cleaving the reducing end C-covalent bond of the sugar chain asparagine compound.
  • glycoproteins A molecule in which a sugar chain is covalently bonded to a protein is called a glycoprotein.
  • Sugar chains in glycoproteins play a role in maintaining the three-dimensional structure of proteins, controlling solubility, and adding protease resistance. Recently, it has been revealed that sugar chains in glycoproteins are involved in vital phenomena such as fertilization, differentiation, signal transduction, canceration, intracellular transport of proteins and regulation of physiological activities. Thus, sugar chains bound to proteins play an important role in various physiological functions. However, since the structures of these sugar chains are diverse and the types are enormous, it is extremely difficult to identify which structure of the sugar chain is involved in life phenomena. In order to elucidate these functions, it is essential to synthesize glycoproteins and glycopeptides with a single-structure sugar chain.
  • Glycoproteins can be divided into two groups based on the differences in the manner of binding between sugar and protein.
  • One is an asparagine-linked sugar chain (N-linked) in which the side chain amino group of asparagine (A sn) is linked to a sugar chain.
  • the other is a mucin-linked sugar chain (O-bonded type) in which a sugar chain is bound to the hydroxyl group of serine (Se r) or threonine (T h r).
  • Patent Document 1 The inventors of the present invention established a method (Patent Document 1) for preparing a large amount of biantennary complex type glycans from chicken eggs by combining an enzyme method and a chemical method. It was shown that an aminated complex-type sugar chain derivative was produced from a complex-type sugar chain possessed, and that the obtained derivative could be selectively introduced into a thiol group of a peptide (Patent Document 2).
  • Preparation of an N-linked sugar chain having a free hydroxyl group at the reducing end of the sugar chain includes a method of cleaving the sugar chain from a sugar chain asparagine and its derivatives and glycoproteins by an enzyme and a method of chemically cleaving it.
  • a hydrazine decomposition method is used as a method of chemically cleaving.
  • Patent Document 1 W 0 0 3/0 0 8 4 3 1
  • Patent Document 2 W 0 2 0 0 4/0 1 1 0 3 6
  • anhydrous hydrazine requires careful handling due to its toxicity and ignitability, and is unsuitable for large-scale processing. Therefore, a safe and effective method for cleaving N-linked sugar chains is required. Yes.
  • An object of the present invention is to provide a method for producing an N-linked sugar chain compound having a free hydroxyl group at the reducing end, using hydrazine hydrate that is safer than anhydrous hydrazine. Disclosure of the invention
  • the present invention relates to the following inventions.
  • R 1 R 2 and R 3 are the same or different and each represents a hydrogen atom or a sugar residue.
  • R 4 represents a hydrogen atom or a fucose residue.
  • Ac represents a acetyl group.
  • R 5 is hydrogen atom, fat Represents a soluble protecting group, an amino acid residue, or a peptide residue, and R 6 represents a force lpoxyl group or a group C OR 7 .
  • R 7 represents an amino acid residue or a peptide residue.
  • the present inventors used hydrazine hydrate that could not be used because of / 3 elimination until now, hydrazine decomposition, followed by substitution with benzylamine compound, purification, and hydrolysis to the reducing end. It has been found that an N-linked sugar chain compound having a free hydroxyl group can be produced.
  • the sugar chain asparagine compound represented by the formula (1) of the present invention includes glycoproteins, glycopeptides, sugar chain asparagine and their derivatives, etc., in which the sugar chain binds to asparagine.
  • the sugar chain compound represented by the formula (2) of the present invention is an N 1-linked sugar chain compound having a free hydroxyl group at the reducing end.
  • RR 2 and R 3 are the same or different and each represents a hydrogen atom or a sugar residue.
  • R 4 represents a hydrogen atom or a fucose residue.
  • Ac represents a acetyl group.
  • R 5 represents a hydrogen atom, a lipophilic protecting group, an amino acid residue, or a peptide residue, and
  • R 6 represents a force lpoxyl group or a group —COR 7 .
  • R 7 represents an amino acid residue or a peptide residue.
  • the sugar residue may be a monosaccharide such as mannose, N-acetyl darcosamine, galactose, or fucose, which may have a hydroxyl group protected, may be substituted with a halogen atom such as fluorine, Two or more of these monosaccharides may be bonded with daricoside to form a sugar chain. Further, it may be a sugar chain containing a sialic acid which may be substituted with a halogen such as fluorine, and whose strong lpoxyl group may be protected.
  • the sugar chain asparagine compound represented by the formula (1) may be a conventionally known or unknown sugar chain asparagine, a high mannose type sugar chain asparagine compound, a complex type sugar chain asparagine compound, a hybrid sugar chain asparagine compound, It may be.
  • the sugar chain compound represented by the formula (2) may be a conventionally known or unknown sugar chain compound, and may be a high mannose type sugar chain compound, a complex type sugar chain compound, or a hybrid sugar chain compound.
  • the lipophilic protecting group is not particularly limited.
  • the introduction of the protecting group may be performed according to a known method such as Protecting groups in Organic chemistry (John Wiley & Sons INC., New York 1991, ISBN 0-471-62301-6).
  • the amino acid residue or peptide residue in R 5 is an amino acid or peptide in which an amino group of asparagine and a force loxyl group are amide-bonded, and is not particularly limited.
  • the amino acid residue or peptide residue in R 7 is an amino acid or peptide in which the carboxy group and amino group of asparagine are amide-bonded, and is not particularly limited.
  • the hydrazine hydrate used in this step can be used as long as it is conventionally known, and hydrazine monohydrate can be used as it is or diluted with water.
  • the concentration of hydrazine monohydrate is as follows. It may be about 20 to 100% by weight, particularly preferably about 40 to 100% by weight.
  • the amount of hydrazine hydrate used is not particularly limited and is 0.8 equivalents or more, preferably 1.0 equivalents or more, based on 1 equivalent of the sugar chain asparagine compound represented by the formula (1). A large excess is preferably used because it is used as a solvent.
  • the reaction in this step is carried out under heating and at the reflux temperature.
  • the sugar chain asparagine compound represented by the formula (1) reacts with hydrazine to form a hydrazino compound represented by the formula (3).
  • the / 3 elimination reaction is represented by the formula (3) in which most or all of the sugar chain asparagine compound represented by the formula (1) is represented by the formula (3). It was found to occur after conversion to a hydrazino sugar chain compound. In other words, S elimination reaction does not occur until most or all of the sugar chain asparagine compound represented by the formula (1) is converted to the hydrazino sugar chain compound represented by the formula (3). Become.
  • this reaction may be carried out until all of the sugar chain asparagine compound represented by the formula (1) is consumed, but it is preferable to terminate the reaction before consumption.
  • the reaction is preferably terminated before formation of the hydrazino sugar chain compound represented by the formula (4) generated by the j6 elimination reaction occurs.
  • the reaction is preferably carried out by thin-layer chromatography (TLC) or mass spectrometry. The reaction can be completed by stopping heating under reflux.
  • the sugar chain asparagine compound represented by the formula (1) has an amide bond-type protecting group such as an acetyl group, the protecting group is eliminated by excess hydrazine to form an amino group. Become. Therefore, N-acetylation must be performed by the action of an acetylating agent.
  • acetylating agent a conventionally known acetylating agent that can be used in the N-acetylating reaction can be used.
  • acetylated halides such as acetyl chloride and acetyl bromide can be exemplified by acetic anhydride.
  • Acetic anhydride can be preferably used.
  • the amount of the acetylating agent used may be about 1 to 20 equivalents, preferably about 1.5 to 10 equivalents, relative to 1 equivalent of the amino group.
  • acetylation reaction using an acetylating agent a conventionally known method can be applied. For example, after the excess hydrazine is distilled off from the reaction solution under reduced pressure, the acetylating agent is allowed to act in the presence of a base. It is made with.
  • the base conventionally known ones can be used. Examples thereof include alkali metal carbonates such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate, and organic bases such as tritylamine, pyridine, etc. Is particularly preferred.
  • the amount of the base used is not particularly limited and can be used in an equal amount or more than the acetylating agent, but it is preferably used in a large excess, for example, an alkali metal carbonate such as sodium hydrogen carbonate. In this case, the saturated aqueous solution may be used in an amount of 1 to;
  • This reaction is carried out in a solvent, and examples of the solvent include water, dimethyl sulfoxide (DMSO), N, N-dimethylformamide (DMF), tetrahydrofuran (THF) and the like. You can mix Water is preferably used. The amount of solvent used is not particularly limited.
  • the amount is usually about 10 to 2000 parts by weight, preferably about 100 to 1000 parts by weight per 1 part by weight of the sugar chain compound represented by (3).
  • the reaction is carried out at -10 to 100, preferably 0 to 50 and is usually completed in about 0.1 to 24 hours, but it is preferable to confirm the progress of the reaction by TLC or mass spectrum. .
  • the compound after the acetylation reaction is represented by the following formula (5).
  • the product containing the hydrazino sugar chain compound represented by the formula (5) obtained as described above is treated with gel filtration column chromatography to obtain fragments such as asparagine residues and j6 desorbed sugar residues. Can be removed.
  • Examples of the acid used include mineral acids such as hydrochloric acid, sulfuric acid and phosphoric acid, carboxylic acids such as formic acid, acetic acid and trifluoroacetic acid, and sulfonic acids such as methanesulfonic acid and ethanesulfonic acid. It is preferable from the viewpoint of safety and ease of use.
  • the amount of the acid used is not particularly limited as long as it is 1 equivalent or more per 1 equivalent of the hydrazino sugar chain compound represented by the formula (5), and 1 to 5 equivalents are preferable. Usually an expression
  • the reaction may be carried out at about 0 to 50 ° C, preferably about 10 to 40 ° C. Usually, the reaction is completed within about 1 to 15 hours, preferably about 2 to 10 hours, but the reaction can be carried out with TLC or mass spectrum. It is preferable to track and confirm the end.
  • a product containing the sugar chain compound represented by the formula (2) can be produced.
  • the sugar chain asparagine compound represented by the formula (1) as a raw material remains, and if the reaction proceeds slightly, the
  • the hydrazino sugar chain represented by (3) is unstable and causes ⁇ elimination over time. Therefore, the sugar chain compound represented by the formula (2) obtained at this stage includes the compound (1),
  • the amine compound is allowed to act in a solvent on the mixture of the sugar chain compound represented by the formula (2) and the other compound obtained above.
  • Examples of the amine compound include monoalkylamines having 1 to 4 carbon atoms such as methylamine, ethylamine, isopropylamine, cyclopropylamine, cyclobutylamine, cyclopentylamine, cyclohexylamine, cycloheptylamine, cyclooctylamine. Examples thereof include cycloalkylamines having 3 to 8 carbon atoms such as amine and benzylamines which may have a substituent.
  • Examples of the substituent of benzylamine that may have a substituent include halogen atoms such as fluorine, chlorine and bromine, alkyl groups having 1 to 4 carbon atoms such as a methyl group, an ethyl group, a propyl group, an isopropyl group and a tert-butyl group. , A methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, an alkoxy group such as a tert-butoxy group, a nitro group, etc., and these substituents can be used alone or at any position on the phenyl ring. Includes those in which ⁇ 5 are the same or differently substituted.
  • benzylamine, P-methoxybenzylamine, and 2,4,5-trimethoxybenzyl can be preferably exemplified, and p-methoxybenzylamine is particularly preferred.
  • the amount of the amine compound used is usually 1 to 20 equivalents, preferably 2 to 10 equivalents, per 1 equivalent of the sugar chain compound represented by the formula (2).
  • This reaction is preferably carried out in the presence of an acid such as camphorsulfonic acid.
  • the amount of the acid used may be 0.01 to 5 equivalents, preferably 0.05 to 1 equivalents, with respect to 1 equivalent of the sugar chain compound represented by the formula (1).
  • solvent used in this reaction examples include water, dimethyl sulfoxide (DMS O), N, N-dimethylformamide (DMF), tetrahydrofuran (TH F) and the like. These may be used alone or in combination of two or more. May be used.
  • the amount of the solvent used is not particularly limited, but is usually about 10 to 2000 parts by weight, preferably about 100 to 1000 parts by weight with respect to 1 part by weight of the sugar chain compound represented by the formula (2).
  • This reaction is usually performed at 0 to 100 ° C, preferably about 10 to 50 ° C, and is usually completed in about 1 to 24 hours. However, the reaction is followed by TLC or mass spectrum, and the raw material disappears. The reaction may be terminated at the time of performing.
  • an amino sugar chain compound represented by the formula (7) in which an amino compound is substituted at the reducing end of the sugar chain can be obtained.
  • This compound is stable to a base; It does not occur and the sugar chain structure can be maintained.
  • the hydrazino sugar chain compound represented by the formula (6) mixed in the raw material of this reaction reacts in the same manner to give the corresponding amino-substituted compound.
  • R 1 , R 2 , R 3 , R 4 and Ac are the same as above.
  • R 8 represents an alkyl group having 1 to 4 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms, or a benzyl group that may have a substituent.
  • examples of the alkyl group having 1 to 4 carbon atoms of R 8 include a methyl group, an ethyl group, and an isopropyl group.
  • examples of the cycloalkyl group having 3 to 8 carbon atoms include a cyclopropyl group and a cyclobutyl group.
  • substituent of the benzyl group which may have a substituent include halogen atoms such as fluorine, chlorine and bromine, carbon numbers such as methyl group, ethyl group, propyl group, isopropyl group and tert-butyl group.
  • substituents can be used alone or at any position on the phenyl ring. And those in which 2 to 5 are the same or differently substituted.
  • benzyl groups a benzyl group, a p-methoxybenzyl group, and a 2,4,5-trimethoxy group can be preferably exemplified, and a p-methoxybenzyl group is particularly preferable.
  • the amino sugar chain compound represented by the formula (7) can be isolated and purified by treating the amino sugar chain compound represented by the formula (7) and other compounds by column chromatography. it can.
  • Separation by chromatography can be appropriately performed by using known chromatography alone or in combination. For example, after purification by gel filtration chromatography, reverse phase column chromatography is used. It can be purified.
  • Examples of the reverse phase column include ODS, Phenyl system, nitrile system, anion exchange system power ram, etc.
  • the amino acid of the amino sugar chain compound represented by the formula (7) The base produces a strong interaction with the octyldecyl group of the ODS column, and has excellent resolution.
  • the separation conditions and the like may be appropriately adjusted with reference to known conditions.
  • the resulting amino sugar chain compound represented by the formula (7) is a novel compound.
  • the target sugar chain compound represented by the formula (2) can be obtained by allowing an acid to act on the amino sugar chain compound represented by the formula (7) isolated by the above chromatography.
  • Examples of the acid used include mineral acids such as hydrochloric acid, sulfuric acid and phosphoric acid, and carboxylic acids such as formic acid, acetic acid and trifluoroacetic acid. Carboxylic acids are preferred, and among them, acetic acid is safe and simple to use. Is preferable.
  • the amount of the acid used is not particularly limited as long as it is 1 equivalent or more with respect to 1 equivalent of the amino sugar chain compound represented by the formula (7), and 1 to 5 equivalents are preferable. Usually, it is preferable to add the acid to such an extent that the aqueous solution of the compound of the formula (7) is sufficiently acidic.
  • the reaction may be carried out at about 0 to 50 ° C, preferably about 10 to 40 ° C. Usually, the reaction is completed within about 1 to 15 hours, preferably about 2 to 10 hours, but the reaction can be carried out using TLC or mass spectrum. It is preferable to track and confirm the end.
  • the obtained sugar chain compound represented by the formula (2) can be purified by chromatography or the like.
  • reaction solution was concentrated to dryness under reduced pressure, and the resulting residue was dissolved in 1 ml of water.
  • sodium hydrogen carbonate powder until saturation, followed by acetic anhydride (0.1 mL).
  • reaction solution is concentrated to dryness under reduced pressure, and the resulting residue is dissolved in 1 ml of water and subjected to gel filtration chromatography (column support: Sepha ex G-25, column size: 16 mmX 345 mm, flow rate: The fraction containing the compound (5-1) was fractionated at 0.8 ml / min, developing solvent: water, and concentrated under reduced pressure.
  • the obtained powder is purified by gel filtration column chromatography (same as above), fractions containing the target compound (2-1) are collected, concentrated under reduced pressure, and the compound (2-1) is collected. ) However, contamination of unreacted raw material derived compounds (1 1 2) and / 3 desorbed compound (8) was observed.
  • ODS column (column support: Co smo si 1 75 C 18 — OPN (manufactured by Nacalai Tesque)), in which 2 Omg of the obtained powder was dissolved in 1 OmM ammonium hydrogen carbonate aqueous solution and completely replaced with 10 mM ammonium hydrogen carbonate aqueous solution, Column size: 0.75X 0.75X 10 cm). After that, 1 OmM ammonium bicarbonate aqueous solution was flowed 5 times the amount of the carrier, and the compound (1_2) was discharged.
  • an N-linked sugar chain compound having a free hydroxyl group at the reducing end can be produced using hydrazine hydrate that is safe for hydrazine decomposition reaction.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Disclosed is a process for production of a sugar chain compound represented by the formula (2), wherein the process comprises reacting a sugar chain asparagine compound represented by the formula (1) with hydrazine hydrate. (1) [wherein R1, R2 and R3 independently represent a hydrogen atom or a sugar residue; R4 represents a hydrogen atom or a fucose residue; Ac represents an acetyl group; R5 represents a hydrogen atom, a lipid-soluble protecting group, an amino acid residue or a peptide residue; and R6 represents a carboxyl group or a group -COR7 where R7 represents an amino acid residue or a peptide residue.] (2) [wherein R1, R2, R3, R4 and Ac are as defined above.]

Description

糖鎖化合物の製造方法  Method for producing sugar chain compound

技術分野 Technical field

本発明は、 糖鎖ァスパラギン化合物の還元末端 C一 Ν結合を切断し、 還元末端 に遊離水酸基を有する糖鎖化合物の製造方法に関する。  The present invention relates to a method for producing a sugar chain compound having a free hydroxyl group at the reducing end by cleaving the reducing end C-covalent bond of the sugar chain asparagine compound.

明 背景技術  Background art

 book

糖鎖がタンパク質と共有結合した分子は糖タンパク質と呼ばれている。 糖タン パク質中の糖鎖はタンパク質の 3次元構造の維持や溶解性の調節、 プロテアーゼ 耐性の付加などの働きを担っている。 最近になり、 糖タンパク質中の糖鎖が受精 や分化、 シグナル伝達、 癌化、 タンパク質の細胞内輸送や生理活性の調節などの 生命現象に関与することが明らかにされつつある。 このように、 タンパク質に結 合した糖鎖は様々な生理機能に重要な役割を果たしている。 しかし、 これら糖鎖 の構造は多様で、 その種類は膨大であるため、 どの構造の糖鎖が生命現象に関与 しているかを特定するのはきわめて困難な状況である。 こういった機能の解明の ためにも、 単一構造の糖鎖を持った糖タンパク質、 糖ペプチドの合成が必要不可 欠である。  A molecule in which a sugar chain is covalently bonded to a protein is called a glycoprotein. Sugar chains in glycoproteins play a role in maintaining the three-dimensional structure of proteins, controlling solubility, and adding protease resistance. Recently, it has been revealed that sugar chains in glycoproteins are involved in vital phenomena such as fertilization, differentiation, signal transduction, canceration, intracellular transport of proteins and regulation of physiological activities. Thus, sugar chains bound to proteins play an important role in various physiological functions. However, since the structures of these sugar chains are diverse and the types are enormous, it is extremely difficult to identify which structure of the sugar chain is involved in life phenomena. In order to elucidate these functions, it is essential to synthesize glycoproteins and glycopeptides with a single-structure sugar chain.

糖タンパク質は糖とタンパク質との結合様式の違いから 2つのグループに分け ることができる。 一つはァスパラギン (A s n ) の側鎖のァミノ基と糖鎖が結合 したァスパラギン結合型糖鎖 (N—結合型) である。 もう一っはセリン (S e r ) ゃトレオニン (T h r ) の水酸基に糖鎖が結合したムチン結合型糖鎖 (〇一 結合型) である。  Glycoproteins can be divided into two groups based on the differences in the manner of binding between sugar and protein. One is an asparagine-linked sugar chain (N-linked) in which the side chain amino group of asparagine (A sn) is linked to a sugar chain. The other is a mucin-linked sugar chain (O-bonded type) in which a sugar chain is bound to the hydroxyl group of serine (Se r) or threonine (T h r).

本発明者等は、 鶏卵より酵素法と化学法を組み合わせることで 2分岐複合型糖 鎖を大量に調製する方法 (特許文献 1 ) を確立し、 糖鎖還元末端に遊離水酸基を 有する複合型糖鎖からアミノ化複合型糖鎖誘導体を製造し、 得られた該誘導体を ペプチドのチオール基に選択的に導入できることを示した (特許文献 2 ) 。 The inventors of the present invention established a method (Patent Document 1) for preparing a large amount of biantennary complex type glycans from chicken eggs by combining an enzyme method and a chemical method. It was shown that an aminated complex-type sugar chain derivative was produced from a complex-type sugar chain possessed, and that the obtained derivative could be selectively introduced into a thiol group of a peptide (Patent Document 2).

糖鎖還元末端に遊離水酸基を有する N—結合型糖鎖の調製には、 糖鎖ァスパラ ギン及びその誘導体や糖タンパク質から酵素により糖鎖を切り出す方法や化学的 に切断する方法がある。 通常化学的に切断する方法としては、 ヒドラジン分解法 が用いられる。 ヒドラジンを、 ヒドラジン水和物や水の存在下で使用した場合、 糖鎖還元末端側の糖が脱離 ( 脱離) するため、 無水ヒドラジンが用いられる。  Preparation of an N-linked sugar chain having a free hydroxyl group at the reducing end of the sugar chain includes a method of cleaving the sugar chain from a sugar chain asparagine and its derivatives and glycoproteins by an enzyme and a method of chemically cleaving it. Usually, a hydrazine decomposition method is used as a method of chemically cleaving. When hydrazine is used in the presence of hydrazine hydrate or water, saccharide on the reducing end side of the sugar chain is eliminated (eliminated), so anhydrous hydrazine is used.

【特許文献 1】 W〇 0 3 / 0 0 8 4 3 1号公報  [Patent Document 1] W 0 0 3/0 0 8 4 3 1

【特許文献 2】 W〇 2 0 0 4 / 0 1 1 0 3 6号公報  [Patent Document 2] W 0 2 0 0 4/0 1 1 0 3 6

しかしながら、 無水ヒドラジンはその毒性や発火性等により、 操作には慎重を 要し、 大量の処理には不向きな試薬であるため、 安全で有効な N—結合型糖鎖の 切り出し方法が求められている。  However, anhydrous hydrazine requires careful handling due to its toxicity and ignitability, and is unsuitable for large-scale processing. Therefore, a safe and effective method for cleaving N-linked sugar chains is required. Yes.

本発明の目的は、 無水ヒドラジンに比し、 安全なヒドラジン水和物を使用して、 還元末端に遊離水酸基を有する N—結合型糖鎖化合物を製造する方法を提供する ことにある。 発明の開示  An object of the present invention is to provide a method for producing an N-linked sugar chain compound having a free hydroxyl group at the reducing end, using hydrazine hydrate that is safer than anhydrous hydrazine. Disclosure of the invention

本発明は、 以下の発明に係る。  The present invention relates to the following inventions.

式 (1 ) で表される糖鎖ァスパラギン化合物にヒドラジン水和物を作用させる ことを特徴とする式 (2 ) で表される糖鎖化合物の製造方法。  A method for producing a sugar chain compound represented by the formula (2), wherein hydrazine hydrate is allowed to act on the sugar chain asparagine compound represented by the formula (1).

Figure imgf000004_0001
Figure imgf000004_0001

[式中、 R 1 R 2及び R 3は同一又は異なって水素原子、 糖残基を示す。 R 4は水 素原子又はフコース残基を示す。 A cはァセチル基を示す。 R 5は水素原子、 脂 溶性の保護基、 アミノ酸残基、 又はペプチド残基を示し、 R6は力ルポキシル基 又は基一 C OR7を示す。 R7は、 アミノ酸残基又はペプチド残基を示す。 ] [Wherein, R 1 R 2 and R 3 are the same or different and each represents a hydrogen atom or a sugar residue. R 4 represents a hydrogen atom or a fucose residue. Ac represents a acetyl group. R 5 is hydrogen atom, fat Represents a soluble protecting group, an amino acid residue, or a peptide residue, and R 6 represents a force lpoxyl group or a group C OR 7 . R 7 represents an amino acid residue or a peptide residue. ]

Figure imgf000005_0001
Figure imgf000005_0001

[式中、 R1, R2、 R3、 R 4及び Acは前記に同じ。 ] [Wherein R 1 , R 2 , R 3 , R 4 and Ac are the same as above. ]

本発明者等は、 これまで /3脱離を生じるために使用できなかったヒドラジン水 和物を使用し、 ヒドラジン分解させ、 引き続きベンジルァミン化合物で置換、 精 製後、 加水分解処理により、 還元末端に遊離水酸基を有する N—結合型糖鎖化合 物を製造することができることを見出した。  The present inventors used hydrazine hydrate that could not be used because of / 3 elimination until now, hydrazine decomposition, followed by substitution with benzylamine compound, purification, and hydrolysis to the reducing end. It has been found that an N-linked sugar chain compound having a free hydroxyl group can be produced.

本発明の式 (1) で表される糖鎖ァスパラギン化合物は、 ァスパラギンに糖鎖 が結合する糖タンパク質、 糖ペプチド又は糖鎖ァスパラギン及びそれらの誘導体 等を包含する。  The sugar chain asparagine compound represented by the formula (1) of the present invention includes glycoproteins, glycopeptides, sugar chain asparagine and their derivatives, etc., in which the sugar chain binds to asparagine.

本発明の式 (2) で表される糖鎖化合物は、 還元末端に遊離水酸基を有する N 一結合型糖鎖化合物である。  The sugar chain compound represented by the formula (2) of the present invention is an N 1-linked sugar chain compound having a free hydroxyl group at the reducing end.

Figure imgf000005_0002
Figure imgf000005_0002

[式中、 R R2及び R3は同一又は異なって水素原子、 糖残基を示す。 R4は水 素原子又はフコース残基を示す。 Acはァセチル基を示す。 R 5は水素原子、 脂 溶性の保護基、 アミノ酸残基、 又はペプチド残基を示し、 R6は力ルポキシル基 又は基—C OR 7を示す。 R7は、 アミノ酸残基又はペプチド残基を示す。 ]

Figure imgf000006_0001
[Wherein, RR 2 and R 3 are the same or different and each represents a hydrogen atom or a sugar residue. R 4 represents a hydrogen atom or a fucose residue. Ac represents a acetyl group. R 5 represents a hydrogen atom, a lipophilic protecting group, an amino acid residue, or a peptide residue, and R 6 represents a force lpoxyl group or a group —COR 7 . R 7 represents an amino acid residue or a peptide residue. ]
Figure imgf000006_0001

[式中、 R1 R2、 R3、 R4及び Acは前記に同じ。 ] [Wherein, R 1 R 2 , R 3 , R 4 and Ac are the same as above. ]

糖残基は、 水酸基が保護されていてもよく、 フッ素等のハロゲン原子で置換さ れていてもよいマンノース、 N—ァセチルダルコサミン、 ガラクトース、 フコー ス等の単糖であってもよく、 これら単糖の 2つ以上がダリコシド結合して糖鎖を 形成したものであってもよい。 また、 フッ素等のハロゲンが置換していてもよく、 力ルポキシル基が保護されていてもよいシアル酸を含んだ糖鎖であってもよい。 即ち、 式 (1) で表される糖鎖ァスパラギン化合物は従来公知又は未知の糖鎖 ァスパラギンであってもよく、 高マンノース型糖鎖ァスパラギン化合物、 複合型 糖鎖ァスパラギン化合物、 混成型糖鎖ァスパラギン化合物であってよい。 また、 式 (2) で表される糖鎖化合物は従来公知又は未知の糖鎖化合物であってもよく、 高マンノース型糖鎖化合物、 複合型糖鎖化合物、 混成型糖鎖化合物であってよい。 脂溶性の保護基とは、 特に制限されるものではなく、 例えば 9一フルォレニル メトキシカルポニル (Fmo c) 基や t一ブチルォキシカルポニル (Bo c) 基、 ァリルォキシカーボネート (A l 1 o c) 基等のカーボネート含有基、 ァセチル (Ac) 基等のァシル基、 ァリル基、 ベンジル基等の保護基等を挙げることがで きる。 また、 当該保護基の導入は、 例えば Protecting groups in Organic chemistry (John Wiley & Sons INC., New York 1991, ISBN 0-471-62301-6) 等 の公知の方法に従って行えばよい。  The sugar residue may be a monosaccharide such as mannose, N-acetyl darcosamine, galactose, or fucose, which may have a hydroxyl group protected, may be substituted with a halogen atom such as fluorine, Two or more of these monosaccharides may be bonded with daricoside to form a sugar chain. Further, it may be a sugar chain containing a sialic acid which may be substituted with a halogen such as fluorine, and whose strong lpoxyl group may be protected. That is, the sugar chain asparagine compound represented by the formula (1) may be a conventionally known or unknown sugar chain asparagine, a high mannose type sugar chain asparagine compound, a complex type sugar chain asparagine compound, a hybrid sugar chain asparagine compound, It may be. In addition, the sugar chain compound represented by the formula (2) may be a conventionally known or unknown sugar chain compound, and may be a high mannose type sugar chain compound, a complex type sugar chain compound, or a hybrid sugar chain compound. . The lipophilic protecting group is not particularly limited. For example, 9-fluorenyl methoxycarbonyl (Fmo c) group, t-butyloxycarbonyl (Bo c) group, aryloxycarbonate (A 1 1 oc ) Groups such as carbonate-containing groups, acetyl groups such as acetyl (Ac) groups, protecting groups such as allyl groups and benzyl groups. The introduction of the protecting group may be performed according to a known method such as Protecting groups in Organic chemistry (John Wiley & Sons INC., New York 1991, ISBN 0-471-62301-6).

R 5におけるアミノ酸残基又はペプチド残基は、 ァスパラギンのァミノ基と力 ルポキシル基がアミド結合したアミノ酸又はペプチドであり、 特に制限されない。 The amino acid residue or peptide residue in R 5 is an amino acid or peptide in which an amino group of asparagine and a force loxyl group are amide-bonded, and is not particularly limited.

R 7におけるァミノ酸残基又はべプチド残基は、 ァスパラギンのカルポキシル 基とアミノ基がアミド結合したアミノ酸又はペプチドであり、 特に制限されない。 本工程で使用するヒドラジン水和物は従来公知のものであれば使用でき、 ヒド ラジン一水和物をそのまま、 又は水で希釈して使用することができ、 ヒドラジン 一水和物の濃度としては 2 0〜1 0 0重量%、 特に好ましくは 4 0〜1 0 0重 量%程度とすればよい。 The amino acid residue or peptide residue in R 7 is an amino acid or peptide in which the carboxy group and amino group of asparagine are amide-bonded, and is not particularly limited. The hydrazine hydrate used in this step can be used as long as it is conventionally known, and hydrazine monohydrate can be used as it is or diluted with water. The concentration of hydrazine monohydrate is as follows. It may be about 20 to 100% by weight, particularly preferably about 40 to 100% by weight.

ヒドラジン水和物の使用量としては、 特に制限されず、 式 (1 ) で表される糖 鎖ァスパラギン化合物 1当量に対して 0. 8当量以上、 好ましくは 1 . 0当量以上 であるが、 通常溶媒をかねて使用するため大過剰量を使用するのがよく、 式 ( 1 ) で表される糖鎖ァスパラギン化合物 1重量部に対して 1〜1 0 0 0 0重量 部、 好ましくは 1 0 0〜5 0 0 0重量部とするのが好ましい。  The amount of hydrazine hydrate used is not particularly limited and is 0.8 equivalents or more, preferably 1.0 equivalents or more, based on 1 equivalent of the sugar chain asparagine compound represented by the formula (1). A large excess is preferably used because it is used as a solvent. 1 to 100 parts by weight, preferably 1 to 100 parts by weight per 1 part by weight of the sugar chain asparagine compound represented by the formula (1) It is preferably 5 0 0 parts by weight.

本工程の反応は加熱下で行い還流温度で行なう。 本反応は式 (1 ) で表される 糖鎖ァスパラギン化合物がヒドラジンと反応して、 式 ( 3 ) で表されるヒドラジ ノ化合物を形成すると考えられる。 本発明者等の検討によれば、 理由は定かでは ないが、 /3脱離反応が、 式 (1 ) で表される糖鎖ァスパラギン化合物の大部分又 は全てが式 ( 3 ) で表されるヒドラジノ糖鎖化合物に変換された後に生じること を見出した。 換言すれば、 式 (1 ) で表される糖鎖ァスパラギン化合物の大部分 又は全てが式 (3 ) で表されるヒドラジノ糖鎖化合物に変換されるまでは) S脱離 反応が生じないことになる。  The reaction in this step is carried out under heating and at the reflux temperature. In this reaction, it is considered that the sugar chain asparagine compound represented by the formula (1) reacts with hydrazine to form a hydrazino compound represented by the formula (3). According to the study by the present inventors, the reason is not clear, but the / 3 elimination reaction is represented by the formula (3) in which most or all of the sugar chain asparagine compound represented by the formula (1) is represented by the formula (3). It was found to occur after conversion to a hydrazino sugar chain compound. In other words, S elimination reaction does not occur until most or all of the sugar chain asparagine compound represented by the formula (1) is converted to the hydrazino sugar chain compound represented by the formula (3). Become.

よって本反応は式 (1 ) で表される糖鎖ァスパラギン化合物が全て消費される まで行なうとしてもよいが、 消費する手前で反応を終了させるのが好ましい。 又 は j6脱離反応によって生じる式 (4 ) で表されるヒドラジノ糖鎖化合物の生成が 生じる前に反応を終了させることが好ましい。 反応は薄層クロマトグラフィー (T L C) 若しくはマススペクトルで追跡して行なうのが好ましい。 反応の終了 は加熱還流を中止することで行なうことができる。  Therefore, this reaction may be carried out until all of the sugar chain asparagine compound represented by the formula (1) is consumed, but it is preferable to terminate the reaction before consumption. Alternatively, the reaction is preferably terminated before formation of the hydrazino sugar chain compound represented by the formula (4) generated by the j6 elimination reaction occurs. The reaction is preferably carried out by thin-layer chromatography (TLC) or mass spectrometry. The reaction can be completed by stopping heating under reflux.

Figure imgf000007_0001
[式中、 R 1 , R R 3及び R 4は前記に同じ。
Figure imgf000007_0001
[Wherein R 1 , RR 3 and R 4 are the same as above.

Figure imgf000008_0001
Figure imgf000008_0001

[式中、 R 1 R 2及び R 3は前記に同じ。 ] [Wherein, R 1 R 2 and R 3 are the same as above. ]

本工程の反応においては、 式 (1 ) で表される糖鎖ァスパラギン化合物にァセ チル基のようなアミド結合型保護基があるため、 過剰のヒドラジンによって当該 保護基が脱離してァミノ基になる。 そのため、 ァセチル化剤を作用させて N—ァ セチル化する必要がある。  In the reaction of this step, since the sugar chain asparagine compound represented by the formula (1) has an amide bond-type protecting group such as an acetyl group, the protecting group is eliminated by excess hydrazine to form an amino group. Become. Therefore, N-acetylation must be performed by the action of an acetylating agent.

ァセチル化剤としては、 N—ァセチル化反応に使用し得る従来公知ァセチル化 剤を使用することができ、 例えば、 ァセチルクロライド、 ァセチルブロマイド等 のァセチルハライドゃ無水酢酸を例示することができ、 無水酢酸が好適に使用で きる。 ァセチル化剤の使用量は、 アミノ基 1当量に対して 1〜2 0当量、 好まし くは 1 . 5〜1 0当量程度とすればよい。  As the acetylating agent, a conventionally known acetylating agent that can be used in the N-acetylating reaction can be used. For example, acetylated halides such as acetyl chloride and acetyl bromide can be exemplified by acetic anhydride. Acetic anhydride can be preferably used. The amount of the acetylating agent used may be about 1 to 20 equivalents, preferably about 1.5 to 10 equivalents, relative to 1 equivalent of the amino group.

ァセチル化剤を使用する N—ァセチル化反応は、 従来公知の方法を適用でき、 例えば前記反応液を減圧下で過剰のヒドラジンを留去後、 塩基の存在下、 ァセチ ル化剤を作用させることで成される。  For the N-acetylation reaction using an acetylating agent, a conventionally known method can be applied. For example, after the excess hydrazine is distilled off from the reaction solution under reduced pressure, the acetylating agent is allowed to act in the presence of a base. It is made with.

塩基としては、 従来公知のものを使用でき、 例えば、 炭酸ナトリウム、 炭酸力 リウム、 炭酸水素ナトリウム等のアルカリ金属炭酸塩、 トリヱチルァミン、 ピリ ジン等の有機塩基等が挙げられるが、 炭酸水素ナトリゥムゃピリジンが特に好ま しい。 塩基の使用量としては、 特に制限されずァセチル化剤に対して等量又はそ れ以上使用することができるが、 大過剰使用するのが好ましく、 例えば炭酸水素 ナトリゥム等のアル力リ金属炭酸塩の場合は飽和水溶液として、 ァセチル化剤 1 重量部に対して 1〜; ί 0 0重量部使用することができる。  As the base, conventionally known ones can be used. Examples thereof include alkali metal carbonates such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate, and organic bases such as tritylamine, pyridine, etc. Is particularly preferred. The amount of the base used is not particularly limited and can be used in an equal amount or more than the acetylating agent, but it is preferably used in a large excess, for example, an alkali metal carbonate such as sodium hydrogen carbonate. In this case, the saturated aqueous solution may be used in an amount of 1 to;

本反応は溶媒中で行なわれ、 溶媒としては、 水、 ジメチルスルホキシド (D M S O) 、 N, N—ジメチルホルムアミド (D M F ) 、 テトラヒドロフラン (T H F ) 等を挙げることができ、 これらを単独又は 2種以上を混合して使用してもよ く、 水が好ましく使用できる。 溶媒の使用量としては特に制限されないが、 式This reaction is carried out in a solvent, and examples of the solvent include water, dimethyl sulfoxide (DMSO), N, N-dimethylformamide (DMF), tetrahydrofuran (THF) and the like. You can mix Water is preferably used. The amount of solvent used is not particularly limited.

(3) で表される糖鎖化合物 1重量部に対して、 通常 10〜2000重量部程度、 好ましくは 100〜1000重量部程度とすればよい。 The amount is usually about 10 to 2000 parts by weight, preferably about 100 to 1000 parts by weight per 1 part by weight of the sugar chain compound represented by (3).

反応は— 10〜 100 、 好ましくは 0〜 50 で行なわれ、 通常 0. 1〜 2 4時間程度で完了するが、 TLCやマススぺクトル等で反応の進行を確認して行 なうのが好ましい。  The reaction is carried out at -10 to 100, preferably 0 to 50 and is usually completed in about 0.1 to 24 hours, but it is preferable to confirm the progress of the reaction by TLC or mass spectrum. .

上記ァセチル化反応後の化合物は下記式 (5) で表される。  The compound after the acetylation reaction is represented by the following formula (5).

Figure imgf000009_0001
Figure imgf000009_0001

(5)  (Five)

[ 〜 4及び Acは上記に同じ。 ] [~ 4 and Ac are the same as above. ]

以上のようにして得られた式 (5) で表されるヒドラジノ糖鎖化合物を含む生 成物をゲルろ過カラムクロマトグラフィーで処理ことによってァスパラギン残基 等の切断片や j6脱離した糖残基を除去することができる。  The product containing the hydrazino sugar chain compound represented by the formula (5) obtained as described above is treated with gel filtration column chromatography to obtain fragments such as asparagine residues and j6 desorbed sugar residues. Can be removed.

得られた式 (5) で表されるヒドラジノ糖鎖化合物を酸により処理することに よって式 (1) で表される糖鎖化合物を含む生成物が得られる。  By treating the obtained hydrazino sugar chain compound represented by the formula (5) with an acid, a product containing the sugar chain compound represented by the formula (1) is obtained.

使用する酸としては、 塩酸、 硫酸、 リン酸等の鉱酸類、 蟻酸、 酢酸、 トリフル ォロ酢酸等のカルボン酸類、 メタンスルホン酸、 エタンスルホン酸等のスルホン 酸類を挙げることができ、 中でも酢酸が安全性や使用簡便性の観点から好ましい。 酸の使用量としては、 式 (5) で表されるヒドラジノ糖鎖化合物 1当量に対し て、 1当量以上であれば特に制限されず、 1〜 5当量が好ましい。 通常は式  Examples of the acid used include mineral acids such as hydrochloric acid, sulfuric acid and phosphoric acid, carboxylic acids such as formic acid, acetic acid and trifluoroacetic acid, and sulfonic acids such as methanesulfonic acid and ethanesulfonic acid. It is preferable from the viewpoint of safety and ease of use. The amount of the acid used is not particularly limited as long as it is 1 equivalent or more per 1 equivalent of the hydrazino sugar chain compound represented by the formula (5), and 1 to 5 equivalents are preferable. Usually an expression

( 5 ) の化合物の水溶液が十分に酸性を示す程度に酸を加えるのが好ましい。  It is preferable to add an acid to such an extent that the aqueous solution of the compound (5) is sufficiently acidic.

反応は 0〜50°C程度、 好ましくは 10〜40°C程度とすればよく、 通常 1〜 15時間程度、 好ましくは 2〜10時間程度で完結するが、 TLCやマススぺク トルで反応を追跡して、 終了を確認するのが好ましい。 以上のようにして式 (2 ) で表される糖鎖化合物を含む生成物を製造すること ができるが、 上記のヒドラジン分解においては、 ;6脱離が生じない段階で反応を 終了させた場合には原料となる式 (1 ) で表される糖鎖ァスパラギン化合物が残 存することになり、 反応がやや進行した場合には |3脱離した式 (4 ) で表される ヒドラジノ糖鎖化合物の N—ァセチル体 (6 ) が混入することになる。 また、 式The reaction may be carried out at about 0 to 50 ° C, preferably about 10 to 40 ° C. Usually, the reaction is completed within about 1 to 15 hours, preferably about 2 to 10 hours, but the reaction can be carried out with TLC or mass spectrum. It is preferable to track and confirm the end. As described above, a product containing the sugar chain compound represented by the formula (2) can be produced. However, in the above hydrazine decomposition, when the reaction is terminated at a stage where 6 elimination does not occur In this case, the sugar chain asparagine compound represented by the formula (1) as a raw material remains, and if the reaction proceeds slightly, the | N-acetyl (6) will be mixed. Also, the expression

( 3 ) で表されるヒドラジノ糖鎖は不安定で時間経過とともに; δ脱離を生じる。 よって、 この段階で得られる式 (2 ) で表される糖鎖化合物には、 化合物 (1 ) 、The hydrazino sugar chain represented by (3) is unstable and causes δ elimination over time. Therefore, the sugar chain compound represented by the formula (2) obtained at this stage includes the compound (1),

( 4 ) 、 ( 6 ) 等の他の化合物の混入が認められる。 Contamination with other compounds such as (4) and (6) is observed.

上記式 (6 ) の化合物は下記に示される。

Figure imgf000010_0001
The compound of the above formula (6) is shown below.
Figure imgf000010_0001

― ( 6 ) ― (6)

1〜!^及び A cは上記に同じ。 ]  1 ~! ^ And A c are the same as above. ]

次に上記で得られた式 (2 ) で表される糖鎖化合物及び他の化合物の混合物に 溶媒中、 ァミン化合物を作用させる。  Next, the amine compound is allowed to act in a solvent on the mixture of the sugar chain compound represented by the formula (2) and the other compound obtained above.

ァミン化合物としては、 例えば、 メチルァミン、 ェチルァミン、 イソプロピル ァミン等の炭素数 1〜4のモノアルキルァミン、 シクロプロピルアミン、 シクロ ブチルァミン、 シクロペンチルァミン、 シクロへキシルァミン、 シクロへプチル ァミン、 シクロォクチルァミン等の炭素数 3〜 8のシクロアルキルァミン、 置換 基を有することのあるベンジルァミン類を挙げることができる。 置換基を有する ことのあるベンジルァミンの置換基としては、 フッ素、 塩素、 臭素等のハロゲン 原子、 メチル基、 ェチル基、 プロピル基、 イソプロピル基、 t e r t—ブチル基 等の炭素数 1〜4のアルキル基、 メトキシ基、 エトキシ基、 プロポキシ基、 イソ プロポキシ基、 t e r t—ブトキシ基等のアルコキシ基、 ニトロ基等を挙げるこ とができ、 これらの置換基が単独又はフエニル環上の任意の位置に、 2〜5個が 同一又は異なって置換しているものを包含する。 これらのベンジルァミン類の中 でもベンジルァミン、 P—メトキシベンジルァミン、 2, 4, 5—トリメトキシべ ンジルを好ましく例示でき、 中でも p—メトキシベンジルァミンが特に好ましい。 ァミン化合物の使用量としては、 式 (2) で表される糖鎖化合物 1当量に対し て、 通常 1〜20当量、 好ましくは 2~10当量とすればよい。 Examples of the amine compound include monoalkylamines having 1 to 4 carbon atoms such as methylamine, ethylamine, isopropylamine, cyclopropylamine, cyclobutylamine, cyclopentylamine, cyclohexylamine, cycloheptylamine, cyclooctylamine. Examples thereof include cycloalkylamines having 3 to 8 carbon atoms such as amine and benzylamines which may have a substituent. Examples of the substituent of benzylamine that may have a substituent include halogen atoms such as fluorine, chlorine and bromine, alkyl groups having 1 to 4 carbon atoms such as a methyl group, an ethyl group, a propyl group, an isopropyl group and a tert-butyl group. , A methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, an alkoxy group such as a tert-butoxy group, a nitro group, etc., and these substituents can be used alone or at any position on the phenyl ring. Includes those in which ~ 5 are the same or differently substituted. Among these benzylamines However, benzylamine, P-methoxybenzylamine, and 2,4,5-trimethoxybenzyl can be preferably exemplified, and p-methoxybenzylamine is particularly preferred. The amount of the amine compound used is usually 1 to 20 equivalents, preferably 2 to 10 equivalents, per 1 equivalent of the sugar chain compound represented by the formula (2).

本反応は、 樟脳スルホン酸等の酸の存在下で行なうのが好ましい。  This reaction is preferably carried out in the presence of an acid such as camphorsulfonic acid.

酸の使用量としては、 式 (1) で表される糖鎖化合物 1当量に対して 0.01 〜5当量、 好ましくは 0.05〜1当量とすればよい。  The amount of the acid used may be 0.01 to 5 equivalents, preferably 0.05 to 1 equivalents, with respect to 1 equivalent of the sugar chain compound represented by the formula (1).

本反応において使用する溶媒としては、 水、 ジメチルスルホキシド (DMS O) 、 N, N—ジメチルホルムアミド (DMF) 、 テトラヒドロフラン (TH F) 等を挙げることができ、 これらを単独又は 2種以上を混合して使用してもよ い。  Examples of the solvent used in this reaction include water, dimethyl sulfoxide (DMS O), N, N-dimethylformamide (DMF), tetrahydrofuran (TH F) and the like. These may be used alone or in combination of two or more. May be used.

溶媒の使用量としては特に制限されないが、 式 (2) で表される糖鎖化合物 1 重量部に対して、 通常 10〜 2000重量部程度、 好ましくは 100〜 1000 重量部程度とすればよい。  The amount of the solvent used is not particularly limited, but is usually about 10 to 2000 parts by weight, preferably about 100 to 1000 parts by weight with respect to 1 part by weight of the sugar chain compound represented by the formula (2).

本反応は、 通常 0〜 100 °C、 好ましくは 10〜 50 °C程度で行なえばよく、 通常 1~ 24時間程度で完結するが、 TLC又はマススぺクトル等で反応を追跡 し、 原料が消失する時点で反応を終了させればよい。  This reaction is usually performed at 0 to 100 ° C, preferably about 10 to 50 ° C, and is usually completed in about 1 to 24 hours. However, the reaction is followed by TLC or mass spectrum, and the raw material disappears. The reaction may be terminated at the time of performing.

本反応により、 糖鎖還元末端にァミノ化合物が置換した式 (7) で表されるァ ミノ糖鎖化合物を得ることができ、 本化合物は塩基に対しても安定で、 ;6脱離反 応を生じず、 糖鎖構造を維持することができる。 なお、 本反応の原料中に混入し た式 (6) で表されるヒドラジノ糖鎖化合物も同様に反応して、 相当するァミノ 置換化合物を与える。

Figure imgf000011_0001
[式中、 R1, R2、 R3、 R4及び Acは前記に同じ。 R8は炭素数 1〜4のアル キル基、 炭素数 3〜8のシクロアルキル基、 置換基を有することのあるべンジル 基を示す。 ] By this reaction, an amino sugar chain compound represented by the formula (7) in which an amino compound is substituted at the reducing end of the sugar chain can be obtained. This compound is stable to a base; It does not occur and the sugar chain structure can be maintained. The hydrazino sugar chain compound represented by the formula (6) mixed in the raw material of this reaction reacts in the same manner to give the corresponding amino-substituted compound.
Figure imgf000011_0001
[Wherein R 1 , R 2 , R 3 , R 4 and Ac are the same as above. R 8 represents an alkyl group having 1 to 4 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms, or a benzyl group that may have a substituent. ]

ここで、 R8の炭素数 1〜4のアルキル基としては、 メチル基、 ェチル基、 ィ ソプロピル基等を挙げることができ、 炭素数 3〜 8のシクロアルキル基としては、 シクロプロピル基、 シクロブチル基、 シクロペンチル基、 シクロへキシル基、 シ クロへプチル基、 シクロォクチル基等を挙げることができる。 置換基を有するこ とのあるべンジル基の置換基としては、 フッ素、 塩素、 臭素等のハロゲン原子、 メチル基、 ェチル基、 プロピル基、 イソプロピル基、 t e r t一ブチル基等の炭 素数 1〜4のアルキル基、 メトキシ基、 エトキシ基、 プロポキシ基、 イソプロボ キシ基、 t e r t一ブトキシ基等のアルコキシ基、 ニトロ基等を挙げることがで き、 これらの置換基が単独又はフエニル環上の任意の位置に、 2〜 5個が同一又 は異なって置換しているものを包含する。 これらのベンジル基の中でもべンジル 基、 p—メトキシベンジル基、 2, 4, 5—トリメトキシ基を好ましく例示でき、 中でも p—メトキシベンジル基が特に好ましい。 Here, examples of the alkyl group having 1 to 4 carbon atoms of R 8 include a methyl group, an ethyl group, and an isopropyl group. Examples of the cycloalkyl group having 3 to 8 carbon atoms include a cyclopropyl group and a cyclobutyl group. Group, cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclooctyl group and the like. Examples of the substituent of the benzyl group which may have a substituent include halogen atoms such as fluorine, chlorine and bromine, carbon numbers such as methyl group, ethyl group, propyl group, isopropyl group and tert-butyl group. An alkyl group, a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, an alkoxy group such as a tert-butoxy group, a nitro group, and the like. These substituents can be used alone or at any position on the phenyl ring. And those in which 2 to 5 are the same or differently substituted. Among these benzyl groups, a benzyl group, a p-methoxybenzyl group, and a 2,4,5-trimethoxy group can be preferably exemplified, and a p-methoxybenzyl group is particularly preferable.

得られた式 (7) で表されるアミノ糖鎖化合物及びその他の化合物をカラムク 口マトグラフィ一で処理することによって、 式 (7) で表されるアミノ糖鎖化合 物を単離精製することができる。  The amino sugar chain compound represented by the formula (7) can be isolated and purified by treating the amino sugar chain compound represented by the formula (7) and other compounds by column chromatography. it can.

クロマトグラフィーでの分離は、 適宜、 公知のクロマトグラフィーを単独で又 は複数組み合わせて用いることにより行なうことができ、 例えばゲルろ過クロマ 卜グラフィ一で精製後、 逆相系のカラムクロマトグラフィーを用いて精製するこ とができる。  Separation by chromatography can be appropriately performed by using known chromatography alone or in combination. For example, after purification by gel filtration chromatography, reverse phase column chromatography is used. It can be purified.

逆相系のカラムとしては、 例えば、 ODS、 Pheny l系、 二トリル系や、 陰イオン交換系の力ラム等を挙げることができるが、 式 (7) で表されるァミノ 糖鎖化合物のァミノ基部が ODSカラムのォク夕デシル基と強い相互作用を生み、 分離能に優れる。 分離条件等は適宜、 公知の条件を参照して調整すればよい。  Examples of the reverse phase column include ODS, Phenyl system, nitrile system, anion exchange system power ram, etc. The amino acid of the amino sugar chain compound represented by the formula (7) The base produces a strong interaction with the octyldecyl group of the ODS column, and has excellent resolution. The separation conditions and the like may be appropriately adjusted with reference to known conditions.

得られる式 (7) で表されるアミノ糖鎖化合物は新規化合物である。 上記クロマトグラフィーにより単離した式 (7) で表されるアミノ糖鎖化合物 に酸を作用させることで目的の式 (2) で表される糖鎖化合物とすることができ る。 The resulting amino sugar chain compound represented by the formula (7) is a novel compound. The target sugar chain compound represented by the formula (2) can be obtained by allowing an acid to act on the amino sugar chain compound represented by the formula (7) isolated by the above chromatography.

使用する酸としては、 塩酸、 硫酸、 リン酸等の鉱酸類、 蟻酸、 酢酸、 トリフル ォロ酢酸等のカルボン酸類を挙げることができ、 カルボン酸類が好ましく、 中で も酢酸が使用上安全且つ簡便で好ましい。  Examples of the acid used include mineral acids such as hydrochloric acid, sulfuric acid and phosphoric acid, and carboxylic acids such as formic acid, acetic acid and trifluoroacetic acid. Carboxylic acids are preferred, and among them, acetic acid is safe and simple to use. Is preferable.

酸の使用量としては、 式 (7) で表されるアミノ糖鎖化合物 1当量に対して、 1当量以上であれば特に制限されず、 1〜 5当量が好ましい。 通常は式 (7) の 化合物の水溶液が十分に酸性を示す程度に酸を加えるのが好ましい。  The amount of the acid used is not particularly limited as long as it is 1 equivalent or more with respect to 1 equivalent of the amino sugar chain compound represented by the formula (7), and 1 to 5 equivalents are preferable. Usually, it is preferable to add the acid to such an extent that the aqueous solution of the compound of the formula (7) is sufficiently acidic.

反応は 0〜 50 °C程度、 好ましくは 10〜 40 °C程度とすればよく、 通常 1〜 15時間程度、 好ましくは 2〜10時間程度で完結するが、 TLCやマススぺク トルで反応を追跡して、 終了を確認するのが好ましい。  The reaction may be carried out at about 0 to 50 ° C, preferably about 10 to 40 ° C. Usually, the reaction is completed within about 1 to 15 hours, preferably about 2 to 10 hours, but the reaction can be carried out using TLC or mass spectrum. It is preferable to track and confirm the end.

得られた式 (2) で表される糖鎖化合物は、 クロマトグラフィー等で精製する ことができる。 発明を実施するための最良の形態  The obtained sugar chain compound represented by the formula (2) can be purified by chromatography or the like. BEST MODE FOR CARRYING OUT THE INVENTION

以下に実施例を挙げて説明するが、 本発明は何らこれら実施例に限定されるも のではない。  Examples will be described below, but the present invention is not limited to these examples.

実施例 1 Example 1

糖鎖ァスパラギン化合物 (1一 1) 1 Omgにヒドラジン水和物 (ヒドラジン 55%) 1 Omlを加えて室温で溶解させた。 これを 100°Cで加熱還流させた。 TLC (イソプロパノール: 1M酢酸アンモニゥム水溶液 = 1 : 1) で反応を追 跡し、 TLC上で原料が消失した時点で加熱還流を止めた。 なお、 糖鎖ァスパラ ギン化合物 (1— 1) においてヒドラジン水和物添加直後に Fmo c基が脱離す るので、 Fmo c基が脱離した糖鎖ァスパラギン化合物を原料として扱った。 Sugar chain asparagine compound (1 1 1) 1 Omg of hydrazine hydrate (hydrazine 55%) 1 Oml was added and dissolved at room temperature. This was heated to reflux at 100 ° C. The reaction was followed by TLC (isopropanol: 1M ammonium acetate aqueous solution = 1: 1), and when the raw material disappeared on TLC, heating and reflux were stopped. In the sugar chain asparagine compound (1-1), since the Fmoc group was released immediately after the addition of hydrazine hydrate, the sugar chain asparagine compound from which the Fmoc group was eliminated was treated as a raw material.

Figure imgf000014_0001
Figure imgf000014_0001

(1-1)  (1-1)

反応液を減圧下で乾固するまで濃縮し、 得られた残渣に水 lmlを加えて溶か した。 この水溶液に炭酸水素ナトリウム粉末を飽和するまで加えた後、 無水酢酸 (0. lmL) を加えた。 反応を TLC (イソプロパノール: 1M酢酸アンモニ ゥム水溶液 =1.5 : 1) でァセチル化の進行を追跡した。 また TLC (イソプ ロパノール: 1M酢酸アンモニゥム水溶液 = 1 : 1) で原料の消失を確認して、 炭酸水素ナトリゥム粉末を反応液の pHが 7〜 8になるように加えて中和した。 反応液を減圧下で乾固するまで濃縮し、 得られた残渣を水 lmlに溶かし、 ゲ ルろ過クロマトグラフィー (カラム担体: S e phad e x G— 25、 カラム サイズ: 16 mmX 345 mm、 流速: 0. 8ml /m i n、 展開溶媒:水) で化合物 (5— 1) を含むフラクションを分取し、 減圧下濃縮した。  The reaction solution was concentrated to dryness under reduced pressure, and the resulting residue was dissolved in 1 ml of water. To this aqueous solution was added sodium hydrogen carbonate powder until saturation, followed by acetic anhydride (0.1 mL). The progress of the acetylation was followed by TLC (isopropanol: 1M ammonium acetate aqueous solution = 1.5: 1). The disappearance of the raw materials was confirmed by TLC (Isopropanol: 1M ammonium acetate aqueous solution = 1: 1), and neutralized by adding sodium hydrogen carbonate powder so that the pH of the reaction solution was 7-8. The reaction solution is concentrated to dryness under reduced pressure, and the resulting residue is dissolved in 1 ml of water and subjected to gel filtration chromatography (column support: Sepha ex G-25, column size: 16 mmX 345 mm, flow rate: The fraction containing the compound (5-1) was fractionated at 0.8 ml / min, developing solvent: water, and concentrated under reduced pressure.

Figure imgf000014_0002
(5-1) 得られた濃縮残渣の 5mgを水 lmlに溶かし、 酢酸 572 ^ 1を加えて酢酸 水溶液とした。 室温で撹拌し、 反応を TLC (イソプロパノール: 1M酢酸アン モニゥム水溶液 =1. 5 : 1) で追跡した。 6. 5時間後、 反応終了を確認し、 1 M水酸化ナトリゥム水溶液で中和し、 凍結乾燥して粉体とした。
Figure imgf000014_0002
(5-1) 5 mg of the obtained concentrated residue was dissolved in 1 ml of water, and acetic acid 572 ^ 1 was added to make an acetic acid aqueous solution. The mixture was stirred at room temperature, and the reaction was followed by TLC (isopropanol: 1M ammonium acetate aqueous solution = 1.5: 1). 6. After 5 hours, the completion of the reaction was confirmed, neutralized with 1 M aqueous sodium hydroxide solution, and lyophilized to obtain a powder.

得られた粉体をゲルろ過カラムクロマトグラフィー (前記条件と同じ。 ) で精 製し、 目的とする化合物 (2— 1) を含むフラクションを分取し、 減圧下濃縮し て化合物 (2— 1) を得た。 ただし、 未反応原料由来の化合物 (1一 2) 及び /3 脱離した化合物 (8) の混入を認めた。  The obtained powder is purified by gel filtration column chromatography (same as above), fractions containing the target compound (2-1) are collected, concentrated under reduced pressure, and the compound (2-1) is collected. ) However, contamination of unreacted raw material derived compounds (1 1 2) and / 3 desorbed compound (8) was observed.

収量: 8. 9mg 〔化合物 (2_ 1) :化合物 (2— 2) :化合物 (8) =9 0 : 8 : 2〕 Yield: 8.9 mg [Compound (2_ 1): Compound (2-2): Compound (8) = 9 0: 8: 2]

化合物 (2— 1) Compound (2-1)

XH-NMR (40 ΟΜΗζ , 2 95 K, HOD = 4. 8 1 ) , 5. 28 (b d 1H, G l cNAc l— H— 1) , 5. 23 ( s , 1 H, Man 4-H- 1) 5. 03 (s, 1 H, Ma n 4' -H- 1) , 4. 86 (s , 1 H, Ma n 3 - H— 1) , 4. 70 (m, 3 H, G 1 c NAc 2, 5, 5' -H- 1) , 4. 53 (d, 2H, Ga 1 6, 6'—H— 1) , 4. 34 (b s, 1 H, Man 3 -H- 2) , 4. 28 (b d, 1 H, Man 4-H- 2) , 4. 20 (b d, 1H, Ma n 4' -H- 2) , 2. 76 (b d d, 2 H, N e u Ac 7 7' -H- 3 e q) , 2. 17 (s, 3 H, Ac) , 2. 16 (s , 6 H, Ac X 2) , 2. 1 3 (s , 6 H, Ac X 3) , 1. 80 (d d, 2 H, Ne uAc 7, 7'— H— 3 ax) . X H-NMR (40 ΟΜΗζ, 2 95 K, HOD = 4. 8 1), 5. 28 (bd 1H, G l cNAc l— H— 1), 5. 23 (s, 1 H, Man 4-H -1) 5. 03 (s, 1 H, Man 4 '-H- 1), 4.86 (s, 1 H, Man 3-H— 1), 4.70 (m, 3 H, G 1 c NAc 2, 5, 5 '-H- 1), 4. 53 (d, 2H, Ga 1 6, 6'—H— 1), 4. 34 (bs, 1 H, Man 3 -H- 2 ), 4.28 (bd, 1 H, Man 4-H- 2), 4.20 (bd, 1H, Man 4 '-H- 2), 2.76 (bdd, 2 H, N eu Ac 7 7 '-H- 3 eq), 2.17 (s, 3 H, Ac), 2.16 (s, 6 H, Ac X 2), 2. 1 3 (s, 6 H, Ac X 3), 1. 80 (dd, 2 H, NeuAc 7, 7'— H— 3 ax).

Ma s s : ES I c a 1 c d f o r 2222, f ound ; 1 1 10 Ma s s: ES I c a 1 c d f o r 2222, f ound; 1 1 10

[ (M-2) _2] [(M-2) _ 2 ]

化合物 (8) Compound (8)

Ma s s c a 1 c d f o r 20 19, f oun d ; 1008. 3 Ma s s c a 1 c d f o r 20 19, f oun d; 1008. 3

[ (M-2) 一2] [(M-2) 1 2 ]

Figure imgf000016_0001
Figure imgf000016_0001

Figure imgf000016_0002
Figure imgf000016_0002

Figure imgf000016_0003
実施例 2
Figure imgf000016_0003
Example 2

実施例 1と同様にして得た化合物 (2- 1) 、 化合物 (1 -2) 及び化合物 (8) の混合物 45mgを DMS〇3m 1に溶解させた。 この溶液に p—メトキ シベンジルァミン 2mlと樟脳スルホン酸 5mgを加え、 恒温層で約 37°Cに維 持して反応させた。 45 mg of a mixture of the compound (2-1), the compound (1-2) and the compound (8) obtained in the same manner as in Example 1 was dissolved in DMS03m1. P-Methoxy in this solution 2 ml of sibenzylamine and 5 mg of camphor sulfonic acid were added, and the reaction was carried out while maintaining the temperature at about 37 ° C in the thermostatic layer.

反応をマススぺクトル (1 110Z— 2ピークの消滅と 1170/— 2ピーク の生成) で追跡し、 反応終了を確認した。 反応液に 1 OmMアンモニア水を加え て 2倍に希釈し、 ゲルろ過カラムクロマトグラフィー (カラム担体: S e ph a d e G— 25、 カラムサイズ: φ 10 mmX 900 mm、 流速: 0.8ml /mi n、 展開溶媒: 5 OmM炭酸アンモニゥム水溶液又はアンモニア水 (pH 9-10) ) で精製し、 化合物 (7— 1) を含有するフラクションを分取し、 減 圧下濃縮し、 凍結乾燥して化合物 (7— 1) の粉末を得た。 ただし、 化合物 (1 -2) 及び化合物 (9) の混入を認めた。  The reaction was followed by mass spectrum (disappearance of 1 110Z-2 peak and formation of 1170/2 peak) to confirm the completion of the reaction. 1 OmM aqueous ammonia is added to the reaction solution to dilute it twice and gel filtration column chromatography (column support: Sephade G-25, column size: φ 10 mmX 900 mm, flow rate: 0.8 ml / min, Developing solvent: Purified with 5 OmM ammonium carbonate aqueous solution or aqueous ammonia (pH 9-10)), fraction containing compound (7-1), fractionated, concentrated under reduced pressure, lyophilized to compound (7- 1) powder was obtained. However, contamination of compound (1-2) and compound (9) was observed.

Figure imgf000017_0001
Figure imgf000017_0001

(7-1)  (7-1)

Figure imgf000017_0002
得られた粉末 2 Omgを 1 OmM炭酸水素アンモニゥム水溶液に溶かし、 10 mM炭酸水素アンモニゥム水溶液で完全に置換した ODSカラム (カラム担体: Co smo s i 1 75 C18— OPN (ナカライテスク株式会社製) 、 カラム サイズ: 0.75X 0. 75X 10 cm) に充填した。 その後、 1 OmM炭酸水素 アンモニゥム水溶液を担体の 5倍量流し、 化合物 (1_2) を流出させた。 その 後、 1 OmM炭酸水素アンモニゥム水溶液:ァセトニトリル (=98 : 2) を担 体の 5倍量流し、 担体を洗浄後、 1 OmM炭酸水素アンモニゥム水溶液:ァセト 二トリル (=96 : 4) を流して、 化合物 (9) の流出後、 化合物 (7— 1) を 分取した。 収量: 9mg
Figure imgf000017_0002
ODS column (column support: Co smo si 1 75 C 18 — OPN (manufactured by Nacalai Tesque)), in which 2 Omg of the obtained powder was dissolved in 1 OmM ammonium hydrogen carbonate aqueous solution and completely replaced with 10 mM ammonium hydrogen carbonate aqueous solution, Column size: 0.75X 0.75X 10 cm). After that, 1 OmM ammonium bicarbonate aqueous solution was flowed 5 times the amount of the carrier, and the compound (1_2) was discharged. Then, 1 OmM ammonium hydrogen carbonate aqueous solution: acetonitrile (= 98: 2) was flowed 5 times the carrier, the carrier was washed, and 1 OmM ammonium hydrogen carbonate aqueous solution: acetonitrile nitrile (= 96: 4) was flowed. After the outflow of Compound (9), Compound (7-1) was collected. Yield: 9mg

化合物 (7— 1) Compound (7— 1)

- NMR (400 MHz, H〇D = 4. 81) , 55. 11 (s, 1 H, Ma n 4 -H- 1) , 4.93 (s, 1 H, Man4'— H— 1) , 4.75 (s , 1 H, Ma n 3 -H- 1) , . 59 (m, 3H, G 1 cNAc 2, 5, 5'— H - 1) , 4.43 (d, 2 H, Ga 1 6, 6'_H - 1) ,  -NMR (400 MHz, H o D = 4. 81), 55. 11 (s, 1 H, Man 4 -H- 1), 4.93 (s, 1 H, Man4'— H— 1), 4.75 ( s, 1 H, Man 3 -H- 1),. 59 (m, 3H, G 1 cNAc 2, 5, 5'— H-1), 4.43 (d, 2 H, Ga 1 6, 6'_H -1),

4.24 (b s , 1H, Ma n 3 -H- 2) , 4. 18 (bd, 1 H, Ma n 4 一 H— 2) , 4. 10 (bd, 1 H, Ma n 4' -H- 2) , 4.24 (bs, 1H, Man 3 -H- 2), 4.18 (bd, 1 H, Man 4 one H-2), 4. 10 (bd, 1 H, Man 4 '-H- 2 ),

2. 65 (b d d, 2H, Ne uAc 7, 7 ' -H- 3 e Q) , 1. 71 (dd, 2H, Ne uAc 7, 7'-H-3 ax) . 2. 65 (b d d, 2H, NeuAc 7, 7'-H-3 e Q), 1.71 (dd, 2H, NeuAc 7, 7'-H-3 ax).

Ma s s : ES I c a 1 c d f o r 2341.8, f ound ;  Ma s s: ES I c a 1 c d f o r 2341.8, f ound;

1169. 9 [ (M - 2) -2] 1169. 9 [(M - 2) - 2]

化合物 (9) Compound (9)

Ma s s : ES I c a l c d f o r 2139.8, f ound ;  Ma s s: ES I c a l c d f o 2139.8, f ound;

1068.4 [ (M - 2) -2] 1068.4 [(M - 2) - 2]

実施例 3 Example 3

実施例 2により得られた化合物 ( 7— 1 ) 3 m gに水 1 m 1を加えて水溶液 (pHI O) とした後、 酢酸約 20 1を加えた。 この時の pHは約 4であった。 反応をマススペクトル (1170/— 2ピークの消滅と 1110ノー 2ピーク の生成) で追跡し、 反応終了を確認した。 反応液に水酸化ナトリウム水溶液を加 えて pH5〜6に調整し、 ゲルろ過カラムクロマトグラフィー (カラム担体: S e p h a d e G— 25、 カラムサイズ: φ 1 OmmX 90 Omm、 流速: 0. 8mlZmi n、 展開溶媒:水) 1 mg of water was added to 3 mg of the compound (7-1) obtained in Example 2 to make an aqueous solution (pHI 2 O), and then about 201 of acetic acid was added. The pH at this time was about 4. The reaction was followed by mass spectrum (disappearance of 1170 / —2 peaks and generation of 1110 no 2 peaks) to confirm the completion of the reaction. Sodium hydroxide aqueous solution is added to the reaction solution to adjust the pH to 5-6, and gel filtration column chromatography (column support: Sephade G-25, column size: φ 1 OmmX 90 Omm, flow rate: 0.8 mlZmin, developing solvent) :water)

で精製し、 得られたフラクションを減圧下濃縮して純度 (98%) の化合物 (2 一 1) を 2. 5mg得た。 The obtained fraction was concentrated under reduced pressure to obtain 2.5 mg of the compound (2 1 1) of purity (98%).

得られた化合物 (2— 1) の NMR及びマススペクトルデータは、 前記実施例 1で得られたものと同一であった。 産業上の利用可能性  The NMR and mass spectral data of the obtained compound (2-1) were the same as those obtained in Example 1. Industrial applicability

本発明の方法によれば、 ヒドラジン分解反応に安全なヒドラジン水和物を使 用して、 還元末端に遊離水酸基を有する N—結合型糖鎖化合物を製造することが できる。  According to the method of the present invention, an N-linked sugar chain compound having a free hydroxyl group at the reducing end can be produced using hydrazine hydrate that is safe for hydrazine decomposition reaction.

Claims

請求の範囲 The scope of the claims 1. 式 (1) で表される糖鎖ァスパラギン化合物にヒドラジン水和物を 作用させることを特徴とする式 (2) で表される糖鎖化合物の製造方法。 1. A process for producing a sugar chain compound represented by formula (2), wherein hydrazine hydrate is allowed to act on a sugar chain asparagine compound represented by formula (1).
Figure imgf000020_0001
Figure imgf000020_0001
[式中、 R1 R2及び R3は同一又は異なって水素原子、 糖残基を示す。 R4は水 素原子又はフコース残基を示す。 Acはァセチル基を示す。 R5は水素原子、 脂 溶性の保護基、 アミノ酸残基、 又はペプチド残基を示し、 R6は力ルポキシル基 又は基一 CO R7を示す。 R7は、 アミノ酸残基又はペプチド残基を示す。 ] [Wherein, R 1 R 2 and R 3 are the same or different and each represents a hydrogen atom or a sugar residue. R 4 represents a hydrogen atom or a fucose residue. Ac represents a acetyl group. R 5 represents a hydrogen atom, a lipophilic protecting group, an amino acid residue, or a peptide residue, and R 6 represents a force lpoxyl group or a group COR 7 . R 7 represents an amino acid residue or a peptide residue. ]
Figure imgf000020_0002
Figure imgf000020_0002
[式中、 R R2、 R3、 R4及び Acは前記に同じ。 ] [Wherein, RR 2 , R 3 , R 4 and Ac are the same as above. ]
2. 糖鎖還元末端側の N—ァセチルダルコサミンが; 6脱離する前にヒド ラジン水和物の作用を終了させることを特徴とする請求項 1記載の製造方法。  2. The production method according to claim 1, wherein the action of hydrazine hydrate is terminated before N-acetylyldarcosamine on the sugar chain reducing end side; 3. (A) 式 (1) で表される糖鎖ァスパラギン化合物にヒドラジン水 和物を作用させる工程、  3. (A) a step of allowing a hydrazine hydrate to act on the sugar chain asparagine compound represented by formula (1), (B) ァセチル化剤を作用させる工程、  (B) a step of acting a acetylating agent, (C) 酸を作用させる工程、  (C) a step of reacting an acid, (D) 炭素数 1〜4のモノアルキルァミン、 炭素数 3〜 8のシクロアルキルアミ ン及び置換基を有することのあるベンジルァミンから選ばれる少なくとも 1種の ァミン化合物を作用させる工程、 (E) カラムクロマトグラフィーで精製する工程、 (D) a step of acting at least one amine compound selected from monoalkylamines having 1 to 4 carbon atoms, cycloalkylamines having 3 to 8 carbon atoms and benzylamine which may have a substituent; (E) a step of purification by column chromatography, (F) 酸を作用させる工程、  (F) a step of reacting an acid, をこの順序で実施することを特徴とする式 (2) で表される糖鎖化合物の製造方 法。 Are carried out in this order. A method for producing a sugar chain compound represented by formula (2): 4. (A) のヒドラジン水和物の作用を、 糖鎖還元末端側の N—ァセチ ルダルコサミンが ^脱離する前に終了させる請求項 3記載の製造方法。  4. The production method according to claim 3, wherein the action of the hydrazine hydrate of (A) is terminated before the N-acetyldarcosamine on the sugar chain reducing terminal side is eliminated. 5. (D) のァミン化合物が、 p—メトキシベンジルァミンである請求 項 3記載の製造方法。  5. The production method according to claim 3, wherein the amine compound (D) is p-methoxybenzylamine. 6. (C) 及び (F) の酸が酢酸である請求項 3記載の製造方法。 6. The process according to claim 3, wherein the acid of (C) and (F) is acetic acid. 7. 式 (7) で表されるアミノ糖鎖化合物。
Figure imgf000021_0001
7. An amino sugar chain compound represented by the formula (7).
Figure imgf000021_0001
[式中、 R R2、 R3、 R4及び Acは前記に同じ。 R8は炭素数 1〜4のアル キル基、 炭素数 3〜 8のシクロアルキル基、 置換基を有することのあるべンジル 基を示す。 ] [Wherein, RR 2 , R 3 , R 4 and Ac are the same as above. R 8 represents an alkyl group having 1 to 4 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms, or a benzyl group which may have a substituent. ]
PCT/JP2007/057614 2006-03-30 2007-03-29 Process for production of sugar chain compound Ceased WO2007114482A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-092702 2006-03-30
JP2006092702A JP2009155353A (en) 2006-03-30 2006-03-30 Method for producing sugar chain compound

Publications (1)

Publication Number Publication Date
WO2007114482A1 true WO2007114482A1 (en) 2007-10-11

Family

ID=38563742

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/057614 Ceased WO2007114482A1 (en) 2006-03-30 2007-03-29 Process for production of sugar chain compound

Country Status (3)

Country Link
JP (1) JP2009155353A (en)
TW (1) TW200804429A (en)
WO (1) WO2007114482A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010163485A (en) * 2009-01-13 2010-07-29 Teijin Ltd Solution of carboxy-polysaccharide

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240279364A1 (en) * 2021-03-12 2024-08-22 Daiichi Sankyo Company, Limited Glycan, and method for producing medicine containing glycan
KR20250064682A (en) * 2022-09-09 2025-05-09 다이이찌 산쿄 가부시키가이샤 Novel oligosaccharides, intermediates for producing the oligosaccharides, and methods for producing them

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003008431A1 (en) * 2001-06-19 2003-01-30 Otsuka Chemical Co.,Ltd. Process for producing sugar chain asparagine derivative
JP2004131424A (en) * 2002-10-10 2004-04-30 Nippon Soda Co Ltd Method for producing 4-mercaptophenols
WO2004058984A1 (en) * 2002-12-24 2004-07-15 Otsuka Chemical Co., Ltd. Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain, and processes for producing these
WO2004060915A2 (en) * 2002-12-03 2004-07-22 Sloan-Kettering Institute For Cancer Research Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003008431A1 (en) * 2001-06-19 2003-01-30 Otsuka Chemical Co.,Ltd. Process for producing sugar chain asparagine derivative
JP2004131424A (en) * 2002-10-10 2004-04-30 Nippon Soda Co Ltd Method for producing 4-mercaptophenols
WO2004060915A2 (en) * 2002-12-03 2004-07-22 Sloan-Kettering Institute For Cancer Research Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
WO2004058984A1 (en) * 2002-12-24 2004-07-15 Otsuka Chemical Co., Ltd. Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain, and processes for producing these

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HSING LING CHENG ET AL.: "Determination of Linkages of Linear and Branched Oligosaccharides Using Closed-Ring Chromophore Labeling and Negative Ion Trap Mass Spectrometry", AMERICAN SOCIETY FOR MASS SPECTROMETRY, vol. 13, no. 11, 2002, pages 1322 - 1330, XP004391529 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010163485A (en) * 2009-01-13 2010-07-29 Teijin Ltd Solution of carboxy-polysaccharide

Also Published As

Publication number Publication date
JP2009155353A (en) 2009-07-16
TW200804429A (en) 2008-01-16

Similar Documents

Publication Publication Date Title
WO2008012949A1 (en) Process for producing di(pyrimidine nucleoside 5'-)polyphosphate
WO2017188042A1 (en) Method for producing monomer for single-stranded nucleic acid molecule
JP7373598B2 (en) Method for producing dinucleoside polyphosphate compounds
CN115215921A (en) Preparation method of connection base drug conjugate and intermediate thereof
WO2019049824A1 (en) Protected l-carnosine derivative, l-carnosine, and method for producing crystalline l-carnosine zinc complex
WO2007114482A1 (en) Process for production of sugar chain compound
EP1777215B1 (en) Method for producing 2-amino-5-iodobenzoic acid
US6156906A (en) Process for the preparation of 5,5'-bi-1H-tetrazole salt
JP2025134950A (en) Methods for preparing oligonucleotides
JPH0959292A (en) Production of 4-aminopyrimidine nucleoside
JPS61263995A (en) Production of cytosine nucleoside
JP2000086607A (en) Production of acylhydrazines
JPH0649716B2 (en) Method for manufacturing netil sewing machine
US7122676B2 (en) Process for the preparation of 5,5′-bi-1H-tetrazolediammonium salts using hydrazine hydrate and dicyan as starting materials
JPH0588717B2 (en)
JP7405991B2 (en) Method for producing uridine 5'-diphosphate (UDP), its salt or its hydrate
JP3023804B2 (en) Method for producing 3'-deoxy-3'-fluorothymidine
JP3596669B2 (en) Method for producing 2'-O-alkylguanosine
JP2995101B2 (en) Method for producing N-protected aspartic anhydride
TW202419441A (en) Method for producing alkylsilyloxy-substituted benzylamine compound
JP4491104B2 (en) Method for producing carbonyl compound
JP3070863B2 (en) Method for producing 2 ', 3'-dideoxypyrimidine nucleosides
JPH08319273A (en) Process for producing N-substituted indole derivative
JP2007137843A (en) Method for producing ribofuranose compound and purine nucleoside compound
WO2002051852A1 (en) Process for producing nonnatural saccharide derivative

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07741050

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 07741050

Country of ref document: EP

Kind code of ref document: A1